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Abstract
Background: Discrepancies between the information that patients have received and the patients'
awareness of their condition have frequently been observed in literature and given a number of
different explanations. The chief contribution of this study is that by following patients over time it
is possible not only to notice any changes in the patients' knowledge or awareness of their disease,
but also to investigate the interview material for possible reasons for those changes. Since the study
is based on two different groups of patients it will also be possible to notice if the category of
disease matters for patients' awareness of their condition.
Methods: Twelve patients with malign haematological diseases or lung cancer were followed with
interviews from diagnosis to cure or death, or at most for two years. The method is qualitative.
Semi-structured interviews were conducted, transcribed into written text, and then used for a
qualitative content analysis.
Results: During the process of analysis four different expressions (subcategories) emerged about
the awareness of patients concerning their health status: informed and aware, not informed and
not aware, aware though not informed, or not aware though informed. Then the search started for
obstacles to the awareness of patients regarding their progressing disease and approaching death.
Four kinds of obstacles were found: due to the physician, the patient, the physician and the patient
in collusion, or neither to the physician nor the patient but the insidious way in which lung cancer
(mostly) and haematological malignancies (occasionally) progress.
Conclusion: To optimize the care of patients who wish to be informed and aware during their
disease, it is important that the health care staff recognizes potential obstacles to the awareness of
patients in order to minimize such obstacles. The physicians could improve their communication
with patients with life-threatening diseases, and avoid having a narrow focus on the treatment
calendar. The patients could be encouraged to have a more proactive attitude in their
communication with their physician.
Background
The purpose of this study was to draw attention to proba-
ble discrepancies between the information the patients
had received from their physician and the awareness
patients had of their condition in all phases of their dis-
ease, from diagnosis until their health of state was termi-
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nal. Even when patients had been informed by their
physician, they sometimes seemed to lack awareness of
their disease. Many explanations have been proposed for
this phenomenon. The physicians fail to address the need
of the patients to be informed [1]. The patients' abilities to
receive information are affected by underlying mistaken
beliefs [2]. The language used by medical professionals
does not always have the same meaning to laymen as to
themselves [3]. Between the physician and the patient,
collusion may be present, with the physician avoiding talk
about death and the patient gratefully accepting every
opportunity to "forget" what is coming [4]. It has also
been emphasized that such collusion might be both what
the patient wants and what the patient needs [5]. The
process of information is also complicated, demanding
both intellectual and psychological understanding of
patients [6]. Finally, the patients have different abilities to
cope with and integrate the bad news into their life [7].
All studies referred to above are close to this one in differ-
ent ways. The chief contribution of this study is that, by
following a group of patients over time, it is possible not
only to notice any changes in the patients' knowledge and
awareness of their disease but also to investigate the inter-
view material for reasons for those changes.
As the study is based on two different groups of patients,
diagnosed with either malign haematological or non-
operable lung cancer, it should also be possible to notice
if the category of patients of this study matters for their
knowledge and/or awareness of their condition.
Before going further, we need to clarify the use in this
study of the two terms in focus: "information" and
"awareness", as they are both burdened with some diffi-
culties. In this study it is the patients' view of information
that we have chosen. In this study the term information is
used only to denote information given to the patients by
their physician. We have listened to the words of patients.
If they said that they had been informed, they were docu-
mented as informed. If they said that they had not been
informed, they were documented as uninformed. The
term awareness is used to acknowledge what patients
know in all phases of their disease, regarding their actual
condition of health, of progressing disease and of
approaching death. Mostly, the information received con-
stitutes the basis for the patients' awareness of their health
status. Nevertheless, it is quite possible that a patient had
been informed but for various reasons acted as if no infor-
mation has been received. Moreover, to be aware is not a
question of either-or, but of being more or less aware. A
patient might be informed and aware of his or her condi-
tion. It might also be possible to find a patient who is
informed, yet not aware of his or her state of health, or
that the patient is aware even though he or she is not
informed.
The aim of the study
The aim of the study was to follow a small group of
severely ill patients with interviews from diagnosis to cure
or death, or at most for two years, to study the patients'
view of information compared to their awareness of their
disease. The first step was to search through the interview
material to notice any changes in the patients' awareness
of their disease. The next step was to search for probable
explanations for such changes. Since this is a qualitative
study the purpose is to describe, interpret and clarify dif-
ferences in the awareness of patients during the trajectory
of their disease to obtain a deeper understanding, and not
to make statistical generalizations. The purpose of the
paper is not to generalize beyond the material in the
paper. No statistical frequencies are stated in the conclu-
sions.
Methods
The materials and methods of this study are the same that
were used in a previous study of ours (Hoff, et al 2007).
These studies have both been based on the recurrent inter-
views with 12 seriously ill patients, 7 patients with malign
haematological diseases (acute lymphocytic leukaemia,
acute myelocytic leukaemia, myeloma) and 5 patients
with non-operable lung cancer diseases (adenocarcinoma
and squamous cell cancer). The patients with acute leu-
kaemia were to be treated curatively, the patients with
lung cancer only in a palliative way. The treatment of the
later was essentially about slowing the progress of the can-
cer, or if possible to stop it, while the patients with acute
leukaemia were expected to have a real chance of recovery.
The decision to include these two categories of patients in
the study was, however, due to the similarities between
them. The outbreak of the disease often comes all of a sud-
den to both categories of patients. All patients were to be
treated with intensive cytostatic regimes. Without treat-
ment they all would have been dead within a few months.
The treatment is estimated to be effective in most cases,
but for many patients the malignancy will be back after
some time. The survival rates are therefore low for both
categories of patients. Only 20% of patients diagnosed
with acute leukaemia are estimated to be alive two years
later [8]. Some patients with myeloma get an aggressive
form of the disease bringing them to death within a year,
while others might live with good quality of life for several
more years to come [9]. Among patients with non-small-
cell lung cancer only 3–7% are estimated to be alive five
years later, while 50% die within seven months [10].
The patients were diagnosed at Örebro University Hospi-
tal, Sweden, and they were consecutively asked by their
physician to join the study. The patients were given both
oral and written information (patient letter) by their phy-
sician. In the patient letter it was stressed that participa-
tion was voluntary and that the patients could withdraw
whenever they wanted without any negative conse-BMC Palliative Care 2008, 7:2 http://www.biomedcentral.com/1472-684X/7/2
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quences for their treatment. A summary description of the
participants and the number of interviews is presented in
Table 1. The letters A-G in the table and in the following
refer to patients with haematological diseases and the let-
ters V-Z to patients with lung cancer.
Out of 11 patients with acute leukaemia or myeloma 10
were asked to participate and 7 of them accepted. Of 9
patients with lung cancer, 7 were asked and 5 accepted.
Exclusion criteria were if the patient was unable to give
informed consent or understand the questions. The inter-
view period was 2002–2005. The settings were either the
hospital or the patient's home. The total number of inter-
views was 88, lasting 5–90 minutes each, depending on
the current health status of the patient. For the distribu-
tion of interviews, see Table 2.
The very first interview followed the interview-guide, see
Additional file 1. Depending on what happened to the
patient new questions emerged, see Additional file 2. The
intention was neither to interview the patients as soon as
possible after they had received their diagnosis, nor to fol-
low the patients during the whole processes of their dying.
The first interview was held from six days to six weeks after
the diagnosis had been given to the patients. All patients
were then expected to have overcome their very first
shocking phase. The interviews came to an end as soon as
the patients said that they were about to die, since further
treatment would not stop the progress of the disease.
For closer information on differences in the distribution
of interviews, ethical considerations, collection of data,
we would like to refer to the above-mentioned previous
study of ours [11].
Method of Analysis
Inspired by an approach used in nursing ethics [12], the
interviews transcribed into written text were used for a
qualitative content analysis. Firstly, all typed material was
read through several times; secondly, all material not rel-
evant to the purpose of this study was excluded. The
remaining material was then divided into three domains
of investigation: the disclosure of the diagnosis and infor-
mation during the first treatment, information during the
second treatment, and information when in terminal
phase. These domains were carefully searched through in
order to establish meaning units and condensed meaning
units. Then the process of coding started with the labelling
and summing up the text passages, all followed and
checked by a co-reader. The codes related to the questions
of knowledge and awareness of the patients were gathered
and then compared to each other. During this process of
analysis four different expressions (subcategories)
emerged about the awareness of patients regarding their
condition: the patients as informed and aware, as not
informed and not aware, as aware though not informed
and as not aware though informed. These four different
expressions were then used as categorization of the aware-
ness of the few patients included in the study.
The next step of the analysis started the investigation of
the latent content of categories, the search for obstacles to
the awareness of patients regarding their progressing dis-
ease and when life came close to an end. Four kinds of
obstacles were found: due to the physician, the patient,
both the physician and the patient or to neither of them.
Results
Four categories of awareness of patients regarding their 
state of health
The categorizations of patients were not static, however.
With new information they changed, as the disease devel-
oped. Initially, all patients declared that they had been
informed in an open and straight way about diagnosis,
treatment plans, possible side effects, as well as of progno-
sis. Thus far, they were all categorized as "informed and
aware". However, to patient V with lung cancer the disease
was progressing. In spite of treatment the cancer was
there. This she was not informed about. In fact, she said,
she had to plead for information, before she got to know
the sad news. She was now categorized as "not informed"
but when knowing later she was re-categorized as
"informed and aware". The remaining four patients with
lung cancer had a sudden and remarkable recovery,
shortly after the treatment had started. Now, feeling well,
the threat of death seemed to be much further away.
"There is more of a hope, I think" (Y: 2). Only one patient,
and only once more, talked about the incurability of the
disease (X: 8). The categorization of these patients then
changed somewhat from "informed and aware" to "not
aware, though informed".
Table 2: The distribution of interviews
Patient Diagnosis/Treatment 1 Treatment 2 Terminally Totally
A3 - - 3
B1 - - 1
C9 2 2 1 3
D3 - - 3
E6 3 1 1 0
F3 - - 3
G1 1 - - 1 1
V2 - 1 3
W6 - 1 7
X1 1 2 1 1 4
Y8 2 1 1 1
Z8 - 1 9
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When the disease recurred it affected the awareness of
patients differently, depending on the category of disease.
For patients with leukaemia, the neutrophile leukocyte
test brought about the first alarm that the malignancy
might be back. Then a bone marrow test was taken to con-
firm it, or not, and the test result was given to the patient
(C: 10, E: 9). These patients therefore remained catego-
rized as "informed and aware". For the patients with lung
cancer the return of cancer seemed to have been hidden
behind different diseases, such as thrombosis (Z), recur-
rent pneumonia and dyspnoea (Y, X) colds and high fever
(W). Regular tests were taken for these diseases and the
test results were continually given to the patients. Never-
theless, they seemed little by little to have lost their
knowledge of their disease. The revival of cancer did not
seem to have become obvious to them until their physi-
cian suggested a second regime of cytostatics (Y: 9), or
until the phase was terminal (X, Z, W). These patients
were categorized as "not aware, though informed".
In terminal phase the patients' awareness differed again.
Two of the patients (C) and (V) received the information
verbally from their physician that the treatment had failed
and that another treatment was considered futile. They
therefore remained "informed and aware", even though
patient V again had to ask before she got the information
(V: 3). Patient E became aware of the transition to the ter-
minal phase, not because of information from her physi-
cian but because of the changing values of all tests taken.
During all the time of her disease she had been following
all test results most carefully. This second time the test val-
ues of haemoglobin, thrombocytes, neutrophile leuko-
cytes changed, patient E understood what it all was about.
Now, she expected a bone marrow test, as before, to be
taken to confirm her state of health as terminal. However,
this time her physician withheld the test. Then there was
no confirmatory test result to convey to the patient, who
nevertheless understood her state as terminal. Therefore
she was categorized as "aware, though not informed". To
patients with lung cancer the X-rays did not reveal the can-
cer to be in progress and death to be close until the last
weeks of their lives. Whenever the cancer turned up in a
manifest way in the tests taken, the patients of both cate-
gories were informed, and categorized as "informed and
aware". So was patient X, even though she declared that
she had not verbally been told that she was in a terminal
phase. Yet, she had understood, she said: "I do not think
he (the physician) has told me so very straight, but he held
my hand and so... so I did understand, what it was all
about" (X:14). She was then categorized as "aware, even
though not informed".
There was also patient Z who did not admit her phase to
be terminal. She would soon be better, she said, two
weeks before her death (Z: 9). Patient W declared himself
to be all right only three days before his death. These two
patients were therefore categorized as "not aware, though
informed".
Four categories of obstacles to the awareness of patients
1) Obstacles due to the physician
Since the physicians are responsible for informing
patients, one might think that the major reason for
patients' lack of knowledge or awareness of their progress-
ing disease must be reluctance on the part of the physi-
cians to give patients bad news. But what we found, from
the interviews with the patients, was that the physicians
had been eager to inform the patients all results of tests
taken. As tests were taken the patients were continually
informed about the results. We even found some patients
(D, F, and G) who complained about the amount of infor-
mation given to them. "Actually, you can't keep it all in
your head. It's too much" (F: 3). These patients wanted to
be informed they said, but not about every test taken.
There was, as already noted, one patient who told the
interviewer that she had had to ask for information,
before she had got the bad news about the failure of treat-
ment (V: 3).
There was also one finding of a physician withholding a
potentially confirmatory bone marrow test (E: 10).
The patients' narratives also revealed that information
from physicians was not only a matter of words. Mostly,
the non-verbal communication seemed to have worked
out positively as for patient X, as noted before. Patient V,
on the other hand, told the interviewer how her physician
had suddenly taken her hand, examined it closely, and
then left her without a word. He had just left. The patient
suspected that the physician had been looking for physi-
cal signs of her approaching death, but found it confusing
that he had been examining her hand and not her cheeks
(V: 3). Ill-functioning non-verbal information left the
patient confused and worried.
Table 1: Study participants and number of interviews
Category of patient No of Interviews Sex Age
7 Hematologic 44 3 men/4 women 37–80 yrs old
5 Lung cancer 44 2 men/3 women 60–71 yrs oldBMC Palliative Care 2008, 7:2 http://www.biomedcentral.com/1472-684X/7/2
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Finally, all patients were asked whether they had talked
with their physician about their approaching death or not.
Only patient C said that he had. Patient V came to do it
but not until she once again had asked for more informa-
tion. Then she said: "Now, I quite often ask how long it
will take before I die, but they are not able to answer! I
find that very strange... I would have appreciated if there
was some kind of statistics... I suppose there is, but they
don't want to tell me" (V: 3). When she finally knew she
added: "Maybe I shouldn't complain. Most of my ques-
tions might have been addressed now, but... still there are
questions they have left without an answer... maybe, those
questions they don't know how to answer, they just skip
those" (V: 3). The interview material reflects a kind of
reluctance on the part of the physicians to talk with the
patients about their approaching death.
2) Obstacles due to the coping strategies of patients
The patients developed different coping strategies. The
words of some patients could easily have led to them
being documented as not informed and/or not aware, and
their coping strategy as an obstacle to their awareness.
Through their answers to follow-up questions, they never-
theless appeared to be both informed and aware.
Some patients talked about their disease as if what was
happening was not happening to them but to someone
else, or that it was not happening at all. "You have to
deceive yourself, you know, as if it is not happening to
you, but to someone else" (X: 3). Patient A acted as if she
did not know much about the danger of her disease. How-
ever, when asked if she knew of anyone who had got the
disease acute leukaemia, she said she knew two people.
They had both died (A: 2, A: 3). Patient W, all through his
disease, simply turned his back on the whole question of
his approaching death. In the last interview (three days
before he died) we even talked about his 70th birthday
which was to come three months later (W: 7). At the same
time he commented for the first time on the presence of
metastases in his body.
We also found that several patients were eager to find sim-
ple excuses when not feeling well. They could have been
overstraining themselves, they said. "You see, I have had
visitors coming Monday, Tuesday, Wednesday, Thursday,
Friday... all week my workmates have been visiting me"
(Z: 6). "It feels hard to notice that your strength is not the
same as only a year ago. But I am a year older now, you
know" (Y: 7). "Now we have finished the work with the
new garage. Maybe that was too much?" (Y: 8). Patient X
likewise blamed herself for having been too busy. "Yester-
day, I was ironing. Probably, that was not very wise of
me... the steam you know... and then I was out in my
wheel chair for two whole hours, too much maybe... or
maybe, I did catch a cold" (X: 8).
3) Obstacles due to collusion between the patient and the physician
Collusions between the physician and patients have
already been explored in a study by The et al, where it is
stated that "both parties colluded in focusing on the treat-
ment calendar and at the same time ignoring the long
term". This is congruent with our finding. Of course, the
patients with lung cancer noted that their health was
declining in spite of recoveries from various attacks of
pneumonia or infections. Yet, only seldom did these
patients have a proactive attitude of asking, except for
patient V as noted. Not even when the patients had some-
times prepared themselves for bad news did they ask for
further information. "...patients seem to accept gratefully
every opportunity offered by doctors to 'forget' the future"
[13].
When patient Y was asked by the interviewer why he did
not ask his physician about his approaching death, he
explained: "The thing is, they can't really tell. There will
always be facts that they don't know anything about" (Y:
10). "The physician hasn't got my timetable" (Y: 11). "I
don't need to die from this. It could be from anything"
(W: 5). "You know, even if I had not been ill I could be
killed by a car or something" (X: 10). Another reason for
not asking the physicians was given by patient G: "They
[the physicians] are really sweet and so... but you don't
want to put more burden on their shoulders" (G: 3).
Another kind of collusion is illustrated by the patients
who did not take much interest in the results of any test
taken. They reckoned that they would be informed when
there was something they ought to know about. "I'm not
one of those who check up the test results. They'll tell me,
I suppose, if there's something I should know" (G: 11).
4) Obstacles due neither to the physician nor the patient, but to the 
insidious progression of the disease
One could have expected that the awareness of patients
depended on the category of disease. The categories were
chosen based on similarities between them, yet in some
ways they differed from each other, as to the side effects of
the cytostatic treatment of those patients. While patients
with haematological diseases were in the course of treat-
ment they often felt sick (nausea), they lost their hair, and
they became hospitalized and strictly isolated. The cyto-
static treatment of patients with lung cancer mostly did
not affect them that hard. These differences in the side
effects of the treatments did have an impact on the
patients' awareness, but there were informed and aware
patients with both categories of disease, and there were
patients from both categories who were not informed and
not aware during their disease. Even if most patients who
were not informed and not aware were found among the
patients with lung cancer, the demarcation line did not
follow the category of disease, but the nature of the dis-
ease's progress. Whether the malignancy progressed grad-BMC Palliative Care 2008, 7:2 http://www.biomedcentral.com/1472-684X/7/2
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ually and insidiously or in a rapid and manifest way
(confirmed in the test results), was decisive for the
patients' awareness. This is the major finding of this study.
As already noted, the revivals of lung cancer most often
started hidden behind recurrent acute diseases, such as
thrombosis (Z), recurrent pneumonia and dyspnoea (Y,
X), colds and high fever (W). For these patients it took a
long time until the progress of cancer was manifested and
possible to identify by X-ray pictures. This is to be com-
pared with patients with leukaemia suffering from infec-
tions and high fever. To them the neutrophile leukocyte
test result was an immediate warning that the malignancy
might be back. If this was the case, a bone marrow test was
taken to confirm the return. However, to one of these
patients with acute leukaemia the second relapse pro-
gressed much more gradually, much more like the
relapses of patients with lung cancer.
Finally, there were the four out of five patients with lung
cancer who, shortly after the cystostatic treatment had
started, had a sudden and remarkable recovery making
them feel so much better. It might not be correct to call
this recovery an obstacle. However, the recovery contrib-
uted to a change of attitude in the patient. Now these
patients were more hopeful. "Now, there is more of a
hope, I think" (Y: 2). Feeling so much better there was no
need for such a hurry, he said (Y: 3).
Discussion
The starting point for us was the finding that all twelve
patients in the study expressed a will to be well informed
throughout the disease, which is congruent with the find-
ings of many other studies [[14-16], and [17]]. If we take
these statements by patients seriously, our aim ought to
be to find out what could possibly be done to reduce the
lack of knowledge and/or awareness of these patients.
Improved disclosure and patients' right to obtain infor-
mation about their condition is usually supported by the
principle of autonomy, and non-disclosure by the princi-
ple of beneficence [18]. However, both practices can be
ethically justified depending on the situation [19].
According to the Kantian way of thinking, autonomy is
the basis for making a man able to act ethically as a person
with responsibility. Autonomy is what is needed for man
to remain human. For our purpose a less sophisticated
interpretation of autonomy will do, according to which
the normative value of information and awareness only
exists when it is supported by the expressed will of
patients or the goals of patients. Thus neither information
nor awareness are intrinsic values [20]. If the patients
instead had expressed an unwillingness to be informed,
we then would have suggested that they should be less
informed. But what we found was that the patients did
want to know, but were not always informed or aware.
What could then be done to reduce the lack of knowledge
and/or awareness in patients?
How to deal with the obstacles due to the physician
According to the interviews with the patients, the physi-
cians seem to have been eager to inform them of all results
of tests taken. Only one exception was found. Why there
was a delay in the informing of patient V we do not know,
we only know that she had to plead for information
before she got the sad news, and that is what we question.
Then there was the finding of a physician withholding a
potentially confirmatory bone marrow test. Without a test
there was of course no test result information to give the
patient. However, withholding of a test might be ethically
justified by the principle of non-malificence, that is, that
the potential harm the test would cause the patient should
not outweigh the benefit it would bring the patient. If you
can not do any good, at least do no harm to the patient.
However, questions arise how as to communicate this to
the patient and how to prevent withholding of a test from
making the patient (more than necessarily) less aware.
Some patients in the study regarded themselves as
informed, albeit non-verbally. When the non-verbal com-
munication worked properly, as for patient X, we have no
ethical objections so far, as we think that the need of this
patient was met. Unfortunately, this was not the case for
patient V, and the question that arises is how to be cau-
tious in the practising of non-verbal communication.
Maybe the message understood without any words will
function best as a predictor of what the physician has
come to tell the patient [21].
When the communication concerned the end of life,
silence became notable. The physicians seem to have left
the hard questions without an answer. If the physicians do
not provide space for such communication with the
patients about their approaching death, who should?
How to deal with the obstacles due to the patients
The patients developed different coping strategies. But
their coping strategies (not even the strategy of denying)
were not really found to be an obstacle to patients being
aware of their health status. On the contrary, we found
that the coping strategies all presupposed that informa-
tion had been given to the patient, even though the infor-
mation then was sometimes transformed into more
bearable messages. According to psychological theories
the coping strategy of denying functions as a defence, not
to be removed or questioned [22,23].
There are patients who genuinely wish to have limited
information, but their number is far smaller than many
physicians assume. Good communication is required inBMC Palliative Care 2008, 7:2 http://www.biomedcentral.com/1472-684X/7/2
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order to be able to differentiate patients who need more
information from those who do not want information.
How to deal with the obstacles due to collusion between 
the physician and the patient
The collusions mostly consisted of focusing on the treat-
ment calendar and at the same time ignoring the long-
term perspective. To reduce the uncertainty of progressing
disease and approaching death, could it be possible for
the physicians to have a more proactive attitude (instead
of waiting for the patients to ask for information)? On the
other hand, could the patients be encouraged to be more
proactive by asking?
The collusion was also of the kind that the patient could,
more or less, leave it to the physician to decide what
would be in the best interest of the patient. This could be
ethically justified if this is in accordance with the
expressed will of the patient. Otherwise, unless the patient
is unconscious, such collusion is paternalistic and may be
questioned.
How to deal with the obstacles due to neither the 
physician nor the patient
Finally, we have come to what we found in this study to
be a major obstacle to patients' awareness of their dis-
ease, namely the insidious way that lung cancer (mostly)
and haematological malignancies (occasionally) progress
in a slow and hidden way behind other diseases. In order
to help these patients to become more aware during the
trajectory of their disease, the question arises whether or
not it would be possible to inform these patients what
most probably is to come. If the physicians know, from
experience with other patients, when the disease most
probably is turning lethal, is there an obligation to inform
the patient even before the malignancy is manifested in
the test results? We believe so and once again we would
like to refer to the principle of autonomy. It is the will of
the patient that should be the determining factor. We
believe in balancing the pros and cons for what seems best
for each patient, even when the malignancy is not yet
manifested in test results. Important for this standpoint is
that the survival rates of patients with the diseases
included in this study are low, as noted. The information
would not have been that urgent, had the survival rates
been higher. But as they are very low we believe that at
least some of these patients would have gained from
receiving more information about the fatal course of the
disease.
How is the physician to inform the patient when the man-
ifested test result is not yet at hand? The problem of com-
municating probabilities and uncertainties deserves to be
explored, but this would lead us too far from the aims of
this study and to do this more research is needed. It will
have to be left for another study.
Limitations, trustworthiness and validity
The limitation and trustworthiness of this study, as with
other qualitative interview studies, are based on the small
number of interviews. Besides, out of the twelve patients
included in the study from start, only seven for various
reasons were followed into the terminal phase (see Table
2). Patient B died four days after the first interview and
three other patients (A, D, F) for various reasons were
excluded from the study after three interviews each and we
do not know what the awareness of those four patients
would have been like in later phases of their disease. Nor
do we know about patient G's awareness in later phases of
the disease. She was followed for two years, but did not
relapse during the period.
Another limitation was that the intention to follow the
patients in a regulated way could not always be realized.
Some prearranged interviews had to be shortened in time
or postponed for days, or even weeks, because of the
patient's current state of health.
Finally, even if the intention was to follow the words of
the patients as closely as possible, there was always the
possibility of misinterpretations or over-interpretations.
To limit such risks confirmatory questions were used, the
process of coding followed and checked by a co-reader,
and critical researchers, physicians and co-readers have
been invited to continuously read and check the interpre-
tations made. According to S. Kvale, valid knowledge
emerges where the consistency and internal logic of state-
ments as well as the research procedure is tested: "valid
knowledge claims emerge as conflicting interpretations
and action possibilities are discussed and negotiated
among the members of a community" [24].
Conclusion
The results of this study indicated four kinds of obstacles
to the awareness of patients of their progressing disease.
To optimize care of patients who wish to be informed and
aware during their disease, it is important that the health
care staff have a sharp ear for recognizing potential obsta-
cles to the awareness of patients in order to minimize such
obstacles. The physicians then should:
￿ not narrowly focus on the treatment calendar
￿ not only deliver the results of each test taken but explain
how it fits together with the entirety of all tests taken
￿ help these patients to "read between the lines" to make
them aware of what probably is to comeBMC Palliative Care 2008, 7:2 http://www.biomedcentral.com/1472-684X/7/2
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￿ communicate better with these patients about the diffi-
cult questions of their approaching death and not wait for
the patients to ask
￿ help these patients to become more aware of when their
disease most probably is turning lethal
Finally, the health care staff could encourage the patients
to have a more proactive attitude in their communication
with their physician.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
GH was the philosophical and ethical supervisor of the
study. He contributed to the conception and design of the
study and has given substantial critique during the process
of writing. GH has approved the final manuscript. LH has
been the interviewer, data collector, analyser and writer.
Additional material
Acknowledgements
I am most grateful for the support of two of the physicians at Örebro Uni-
versity Hospital: Ulf Tidefelt as medical supervisor concerning patients with 
haematological diseases Lars Thaning as medical supervisor concerning the 
patients with lung cancer.
Financially, the study has been supported by Swedish Medical Association 
(Svenska Läkarförbundet) Stockholm, Sweden Diocese of Strängnäs, Swe-
den.
References
1. Quirt CF, Mackillop WJ, Ginsburg AD, Sheldon L, Brundage M, Dixon
P, Ginsburg L: Do doctors know when their patients don't? A
survey of doctor-patient communication in lung cancer.  Lung
Cancer 1997, 18:1-20.
2. Farell MH, Murphy MA, Schneider CE: How Underlying Patient
Beliefs Can Affect Physician-Patient Communication about
Prostate-Specific Antigen Testing.  Effective Clinical Practice 2002,
5:120-129.
3. Chapman K, Abraham C, Jenkins V, Fallowfield L: Lay understand-
ing of terms used in cancer consultations.  Psycho-Oncology 2003,
12:557-566.
4. The A-M, Hak T, Koeter G, van der Walk G: Collusion in doctor-
patient communication about imminent death; an ethno-
graphic study.  BMJ 2000, 321:1376-1381.
5. O'Rourke N, Barett A, Jones R, Featherstone C, Hughes V: Patients
rarely regret optimism.  BMJ 2001, 322:1062. (letter).
6. Schneider CE: Reaching Disclosure.  Hastings Centre Report 2005,
35:12-13.
7. Fallowfield L: Truth sometimes hurts but deceit hurts more.
Ann N Y Acad Sci 1997, 809:525-36.
8. Åström M, Bodin L, Tidefelt U: Adjustment in Incidence Rates
after an Estimate of Completeness and Accuracy in Registra-
tion of Acute Leukemias in a Swedish Population.  Leuk Lym-
phoma 2001, 41:559-570.
9. Nordic Myeloma Study Group (NMSG) Nordiskt vårdpro-
gram för Myelom  2001 [http://www.Nordic-myeloma.org].
10. Scagliotti GV, Kortsik C, Dark GG, Price A, Manegold C, Rosell R,
O'Brien M, Peterson PM, Castellano D, Selvaggi G, Novello S, Blatter
J, Kayitalire L, Crino L, Paz-Ares L: Pemetrexed Combined With
Oxaliplatin or Carboplatin as First-Line Treatment in
Advanced Non-Small Cell Lung Cancer: A Multicenter, Ran-
domized, Phase II Trial.  Clin Cancer Res 2005, 11:690-696.
11. Hoff L, Tidefelt U, Thaning L, Hermerén G: In the shadow of bad
news – Views of patients with acute leukaemia, myeloma or
lung cancer about information, from diagnosis to cure or
death.  BMC Palliat Care 2007, 6:1.
12. Graneheim UH, Lundman B: Qualitative content analysis in
nursing research: concepts, procedures and measures to
achieve trustworthiness.  Nurse Educ Today 2004, 24:105-112.
13. The A-M, Hak T, Koeter G, van der Walk G: Collusion in doctor-
patient communication about imminent death; an ethno-
graphic study.  BMJ 2000, 321:1376-1381.
14. Kirk P, Kirk I, Kristjanson LJ: What do patients receiving pallia-
tive care for cancer and their families want to be told? A
Canadian and Australian qualitative study.  BMJ 2004,
328:1343.
15. Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N,
MacLeod C, Tattersall MH: Communicating with realism and
hope; incurable cancer patients' views on the disclosure of
prognosis.  J Clin Oncol 2005, 23:1278-1288.
16. Jenkins V, Fallowfield L, Saul J: Information needs of patients with
cancer: results from a large study in UK cancer centres.  Br J
Cancer 2001, 84:48-51.
17. Hoff L, Tidefelt U, Thaning L, Hermerén G: In the shadow of bad
news – Views of patients with acute leukaemia, myeloma or
lung cancer about information, from diagnosis to cure or
death.  BMC Palliat Care 2007, 6:1.
18. Beauchamp TL, Childress JF: Principles of biomedical ethics 5th edition.
Oxford University Press, New York; 2001. 
19. Schapira L: Palliative Information: Doctor-Patient Communi-
cation.  Semin Oncol 2005, 32:139-144.
20. Beauchamp TL, Childress JF: Principles of biomedical ethics 5th edition.
Oxford University Press, New York; 2001. 
21. Maynard DW: How to tell patients bad news: the strategy of
'forecasting'.  Cleve Clin J Med 1997, 64:181-2.
22. Fallowfield L: Truth sometimes hurts but deceit hurts more.
Ann N Y Acad Sci 1997, 809:525-36.
23. Cullberg J: Dynamisk Psykiatri (in Swedish) Arlöv: Berlings; 1984:74-79. 
24. Kvale S: InterViews: An Introduction to Qualitative Research Interviewing
Thousand Oaks, London, New Delhi: Sage Publications; 1996:236-48. 
Pre-publication history




Interview guide (to the first interview with each patient).




Interview guide (to remaining interviews).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
684X-7-2-S2.doc]